Simultaneous determination of amlodipine and telmisartan from pharmaceutical products by way of capillary electrophoresis

1. Alnajjar A.O.: Validation of a capillary electrophoresis method for the simultaneous determination of amlodipine besylate and valsartan in pharmaceuticals and human plasma. J. AOAC Int., 94, 498, 2011.10.1093/jaoac/94.2.498Search in Google Scholar

2. Chabukswar A.R. et al.: Simultaneous HPTLC estimation of telmisartan and amlodipine besylate in tablet dosage form. Arch. Appl. Sci. Res., 2, 94, 2010.Search in Google Scholar

3. Chrysant S.G.: Using fixed-dose combination therapies to achieve blood pressure goals. Clin. Drug Investig., 28, 713, 2008.10.2165/00044011-200828110-0000518840014Search in Google Scholar

4. Ebeid W. et al.: Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE). Pharmazie, 70, 368, 2015.Search in Google Scholar

5. Hefnawy M.M., Sultan M., Al-Johar H.: Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations. J. Liq. Chrom. Rel. Technol., 32, 2923, 2009.Search in Google Scholar

6. Hillaert S., van de Bossche W.: Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal., 31, 329, 2003.Search in Google Scholar

7. Hirpara K.P. et al.: UV spectrophotometric determination for simultaneous estimation of amlodipine besylate and telmisartan in combination. J. Pharm. Sci. Bio. Res., 2, 133, 2012.Search in Google Scholar

8. Kondawar M.S. et al.: UV spectrophotometric estimation of amlodipine besylate and telmisartan in bulk drug and dosage form by multiwavelenght analysis. Int. J. Pharm. Tech. Res., 3, 1274, 2011.Search in Google Scholar

9. Rajeswari A. et al.: RP-HPLC method development and validation for simultaneous estimation of amlodipine besylate and telmisartan in tablet dosage forms. Int. J. Pharm. Res. Anal., 3, 13, 2013.Search in Google Scholar

10. Ram C.V.: Fixed-dose triple-combination treatments in the management of hypertension. Manag. Care, 22, 45, 2013.Search in Google Scholar

11. Rowan C.G. et al.: Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines. Pharmacoepidemiol. Drug. Saf., 23, 1294, 2014.10.1002/pds.369425171163Search in Google Scholar

12. Segura J., Ruilope L.M.: Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension. Integr. Blood Press. Control., 4, 27, 2011.Search in Google Scholar

13. Suresh Kumar G.V., Rajendraprasad Y.: Development and validation of reversed-phase HPLC method for simultaneous estimation of telmisartan and amlodipine in tablet dosage form. Int. J. Pharm. and Pharm. Sci. 2, 128, 2010.Search in Google Scholar

14. Thomas A.B. et al.: Simultaneous spectrophotometric estimation of amlodipine besylate and telmisartan in tablet dosage form. Int. J. Pharm. Tech. Res., 2, 1334, 2010.Search in Google Scholar

15. Wan X., Ma P., Zhang X.: A promising choice in hypertension treatment: Fixed-dose combinations. Asian J. Pharm. Sci., 9, 1, 2014.Search in Google Scholar